{"version":"1.0","provider_name":"\u682a\u5f0f\u4f1a\u793e\u30de\u30a4\u30af\u30ed\u30f3","provider_url":"https:\/\/microncro.com","author_name":"kanahara@micron-kobe.com","author_url":"https:\/\/microncro.com\/archives\/post\/author\/kanaharamicron-kobe-com\/","title":"FDA Guidance Clinical Trial Imaging Endpoint Process Standards 2 -Micron\u2019s experience- - Micron, Inc.","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"UD6h2d4RJl\"><a href=\"https:\/\/microncro.com\/en\/resources\/video-fda-guidance-part-2\/\">FDA Guidance Clinical Trial Imaging Endpoint Process Standards 2 -Micron\u2019s experience-<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/microncro.com\/en\/resources\/video-fda-guidance-part-2\/embed\/#?secret=UD6h2d4RJl\" width=\"600\" height=\"338\" title=\"&#8220;FDA Guidance Clinical Trial Imaging Endpoint Process Standards 2 -Micron\u2019s experience-&#8221; &#8212; \u682a\u5f0f\u4f1a\u793e\u30de\u30a4\u30af\u30ed\u30f3\" data-secret=\"UD6h2d4RJl\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/microncro.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","thumbnail_url":"https:\/\/microncro.com\/wp-content\/uploads\/2026\/05\/36_thumb_video-2-1024x517-1.png","thumbnail_width":1024,"thumbnail_height":517,"description":"FDA has announced one guidance specified in the imaging study, \u201cClinical Trial Imaging Endpoint Process Standards\u201d in 2018. In this Part 2, we share how we implement FDA guidance into our imaging study process."}